Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation

Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation

The molecule “T cell immunoreceptor with immunoglobulin and ITIM domain,” or TIGIT, has recently received much attention as a promising target in the treatment of various malignancies. In spite of the quick progression of anti-TIGIT antibodies into clinical testing both as monotherapy and in combina...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Jin-Hwan Han, Mingmei Cai, Jeffery Grein, Samanthi Perera, Hongmei Wang, Mike Bigler, Roenna Ueda, Thomas W. Rosahl, Elaine Pinheiro, Drake LaFace, Wolfgang Seghezzi, Sybil M. Genther Williams
स्वरूप: लेख
भाषा:English
प्रकाशित: Frontiers Media S.A. 2020-10-01
श्रृंखला:Frontiers in Immunology
विषय:
TIGIT
FcγR
myeloid cells
combination cancer immunotherapy
costimulatory molecules
immune checkpoint blockade
ऑनलाइन पहुंच:https://www.frontiersin.org/article/10.3389/fimmu.2020.573405/full

इंटरनेट

https://www.frontiersin.org/article/10.3389/fimmu.2020.573405/full

समान संसाधन